Transcribed Image Text from this Question
32. According to the current SNMMI guideline for cardiac perfusion imaging patients who fail to demonstrate myocardial viability with conventional SPECT techniques may benefit from imaging using the radiopharmaceucal particularly those patients with marked left ventricular dysfunction. 33. Identify a potential adverse effect of any imaging agent or drug (of your choice) currently used in nuclear medical imaging? What is the drug/imaging agent, for what purpose is it used and, pathophysiologically, how does this adverse condition arise and can it be treated and, if so, how?
(Visited 3 times, 1 visits today)